Clinical Trial Update: Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the efficacy and safety of silodosin for voiding dysfunction associated with neurogenic bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder
• Voiding Dysfunction

Drugs mentioned

• Silodosin (Silodosin)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Neurogenic Bladder, Voiding Dysfunction | Phase 4 | Status: COMPLETED